Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes. [electronic resource]
Producer: 20160310Description: 1379-94 p. digitalISSN:- 1476-5381
- Cells, Cultured
- Dose-Response Relationship, Drug
- Down-Regulation -- drug effects
- Hep G2 Cells
- Hepatocytes -- drug effects
- Humans
- Lipoproteins, LDL -- chemistry
- Lovastatin -- chemistry
- Lymphocytes -- cytology
- Male
- Raloxifene Hydrochloride -- chemistry
- Receptors, LDL -- metabolism
- Selective Estrogen Receptor Modulators -- chemistry
- Structure-Activity Relationship
- Tamoxifen -- chemistry
- Toremifene -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.